CRAVIT Side Effects

6657375-2 | Conjunctival Hyperaemia, Dermatitis Exfoliative, Hyperthermia
on Dec 18, 2009 Male patient from JAPAN , 85 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, dermatitis exfoliative, hyperthermia. Cravit dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ).

6657052-8 | Eosinophilic Pneumonia
Patient was taking Cravit (View Usage). Patient had the following side effects: eosinophilic pneumonia on Mar 13, 2010 from JAPAN Additional patient health information: Female patient , 78 years of age, . Cravit dosage: . During the same period patient was treated with MUCODYNE (View Mucodyne Review and Mucodyne Label ), CONSTAN (View Constan Review and Constan Label ), AMOBAN (View Amoban Review and Amoban Label ), CLARITH (View Clarith Review and Clarith Label ). Patient was hospitalized.

6655480-8 | Cardiac Failure Congestive, Interstitial Lung Disease, Respiratory Failure
Adverse event was reported on Dec 18, 2009 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with prostatitis, pulmonary mycosis, cough, herpes zoster and. Location: JAPAN , weighting 123.5 lb, After Cravit was administered, patient had the following side effects: cardiac failure congestive, interstitial lung disease, respiratory failure. During the same period patient was treated with ITRIZOLE (View Itrizole Review and Itrizole Label ), EPHEDRA TEAS (View Ephedra Teas Review and Ephedra Teas Label ), PELEX (View Pelex Review and Pelex Label ), SHOUSEIRYUUTOU (View Shouseiryuutou Review and Shouseiryuutou Label ), FLOMOX (View Flomox Review and Flomox Label ), SHAKUYAKUKANZOUTOU (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

6655091-4 | Status Epilepticus
on Mar 15, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with cystitis and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: status epilepticus. Cravit dosage: . Patient was hospitalized.


6652711-5 | Interstitial Lung Disease, Respiratory Failure
on Mar 15, 2010 Female patient from JAPAN , 57 years of age, was diagnosed with infection (What is infection?), cough, diarrhoea, pyrexia and was treated with Cravit (View Usage). Patient had the following side effects: interstitial lung disease, respiratory failure. Cravit dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), CLARITH (View Clarith Review and Clarith Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ).

6652704-8 | Dysphonia, Hypoaesthesia
Patient was taking Cravit (View Usage). After Cravit was administered, patient had the following side effects: dysphonia, hypoaesthesia on Mar 15, 2010 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with pharyngitis and. Cravit dosage: . Patient was hospitalized.

6643835-7 | Abdominal Distension, Blood Creatine Increased, Electrocardiogram Qt Prolonged, Overdose, Tachycardia, Ventricular Extrasystoles
Adverse event was reported on Mar 11, 2010 by a Female patient taking Cravit (View Usage) (Dosage: ) was diagnosed with enteritis infectious, hypertension, cerebral infarction, constipation (What is constipation?), eczema (What is eczema?) and. Location: JAPAN , 83 years of age, Patient experienced the following unwanted or unexpected effects: abdominal distension, blood creatine increased, electrocardiogram qt prolonged, overdose, tachycardia, ventricular extrasystoles. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIOVAN (View Diovan Review and Diovan Label ), PLAVIX (View Plavix Review and Plavix Label ), PLETAL (View Pletal Review and Pletal Label ), LAC B (View Lac B Review and Lac B Label ), ALENAPION (View Alenapion Review and Alenapion Label ), MILMAG (View Milmag Review and Milmag Label ), MYSER (2 In One Day) (View Myser Review and Myser Label ).

6641600-8 | Blood Pressure Decreased
on Mar 09, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Cravit (View Usage). Patient had the following side effects: blood pressure decreased. Cravit dosage: . During the same period patient was treated with DASEN (View Dasen Review and Dasen Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), COLDRIN (View Coldrin Review and Coldrin Label ), ISODINE GARGLE (View Isodine Gargle Review and Isodine Gargle Label ).

6640314-8 | Hypoglycaemia
on Mar 10, 2010 Male patient from JAPAN , 84 years of age, was diagnosed with pneumonia (What is pneumonia?), diabetes mellitus and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: hypoglycaemia. Cravit dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ).

6619578-2 | Interstitial Lung Disease, Pulmonary Fibrosis
Patient was taking Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?) on Feb 24, 2010 from JAPAN Additional patient health information: Male patient , 51 years of age, was diagnosed with upper respiratory tract inflammation and. Cravit dosage: . During the same period patient was treated with TRANSAMIN (View Transamin Review and Transamin Label ), FLOMOX (View Flomox Review and Flomox Label ), LOXOT (View Loxot Review and Loxot Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), TOWATHIEN (View Towathien Review and Towathien Label ). Patient was hospitalized.

6618466-5 | Interstitial Lung Disease, Pulmonary Fibrosis
Adverse event was reported on Feb 24, 2010 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with upper respiratory tract inflammation and. Location: JAPAN , 51 years of age, Patient had the following side effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with TRANSAMIN (View Transamin Review and Transamin Label ), FLOMOX (View Flomox Review and Flomox Label ), LOXOT (View Loxot Review and Loxot Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), TOWATHIEN (View Towathien Review and Towathien Label ). Patient was hospitalized.

6617033-7 | Gaze Palsy, Loss Of Consciousness, Toxic Encephalopathy, Vomiting
on Jan 15, 2010 Female patient from JAPAN , 31 years of age, was diagnosed with cystitis and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: gaze palsy, loss of consciousness, toxic encephalopathy, vomiting. Cravit dosage: . Patient was hospitalized.

6615482-4 | Liver Disorder, Renal Disorder
on Jan 15, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, renal disorder. Cravit dosage: . During the same period patient was treated with ISEPAMICIN SULFATE (View Isepamicin Sulfate Review and Isepamicin Sulfate Label ). Patient was hospitalized.

6611686-5 | Leukopenia, Nephrogenic Anaemia, Nephropathy
Patient was taking Cravit (View Usage). Patient had the following side effects: leukopenia, nephrogenic anaemia, nephropathy on Feb 22, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with enterocolitis and. Cravit dosage: . During the same period patient was treated with LAC B (View Lac-b Review and Lac-b Label ), DIASTASE (View Diastase Review and Diastase Label ). Patient was hospitalized.

6609966-2 | Cardiac Failure Congestive, Interstitial Lung Disease, Respiratory Failure
Adverse event was reported on Dec 14, 2009 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with prostatitis, pulmonary mycosis, cough, herpes zoster and. Location: JAPAN , weighting 123.5 lb, After Cravit was administered, patient had the following side effects: cardiac failure congestive, interstitial lung disease, respiratory failure. During the same period patient was treated with ITRIZOLE (View Itrizole Review and Itrizole Label ), EPHEDRA TEAS (View Ephedra Teas Review and Ephedra Teas Label ), PELEX (View Pelex Review and Pelex Label ), SHOUSEIRYUUTOU (View Shouseiryuutou Review and Shouseiryuutou Label ), FLOMOX (View Flomox Review and Flomox Label ), SHAKUYAKUKANZOUTOU (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

6588809-X | Duodenal Ulcer
on Feb 10, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with campylobacter gastroenteritis, enteritis infectious, reflux oesophagitis and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal ulcer. Cravit dosage: . During the same period patient was treated with LEBENIN (View Lebenin Review and Lebenin Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6588807-6 | Gastric Ulcer, Nephritis Allergic, Pyrexia, Rash
on Feb 10, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with endocarditis (What is endocarditis?) and was treated with Cravit (View Usage). Patient had the following side effects: gastric ulcer, nephritis allergic, pyrexia, rash (What is rash?). Cravit dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), PENICILIN G (View Penicilin G Review and Penicilin G Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ). Patient was hospitalized.

6588806-4 | Dyspnoea, Eczema, Erythema
Patient was taking Cravit (View Usage). After Cravit was administered, patient had the following side effects: dyspnoea, eczema (What is eczema?), erythema on Feb 09, 2010 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with infection prophylaxis and. Cravit dosage: . Patient was hospitalized.

6588805-2 |
Adverse event was reported on Feb 10, 2010 by a Female patient taking Cravit (View Usage) (Dosage: ) was diagnosed with pharyngitis, laryngitis, hypertension and. Location: JAPAN , 80 years of age, . During the same period patient was treated with LYSOZYME HYDROCHLORIDE (View Lysozyme Hydrochloride Review and Lysozyme Hydrochloride Label ), AZUNOL (View Azunol Review and Azunol Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), ATELEC (Initiated Befor Starting Levofloxacin) (View Atelec Review and Atelec Label ), DIOVANE (Initiated Before Starting Levofloxacin) (View Diovane Review and Diovane Label ).

6588797-6 | Abdominal Discomfort, Dyspnoea, Peripheral Coldness, Somnolence
on Feb 10, 2010 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with acute sinusitis, pharyngitis, gastritis prophylaxis and was treated with Cravit (View Usage). Patient had the following side effects: abdominal discomfort, dyspnoea, peripheral coldness, somnolence. Cravit dosage: . During the same period patient was treated with EBASTINE (View Ebastine Review and Ebastine Label ), ANTOBRON (View Antobron Review and Antobron Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), PONTAL (View Pontal Review and Pontal Label ). Patient was hospitalized.

6582031-9 | Superinfection
on Feb 04, 2010 Male patient from JAPAN , weighting 165.3 lb, was diagnosed with liver abscess, hypertension, carotid artery stenosis, constipation (What is constipation?), insomnia, acute coronary syndrome and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: superinfection. Cravit dosage: . During the same period patient was treated with TIENAM (View Tienam Review and Tienam Label ), LASIX (View Lasix Review and Lasix Label ), WARFARIN (View Warfarin Review and Warfarin Label ), IMIDAPRIL (View Imidapril Review and Imidapril Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), MIYA BM (View Miya Bm Review and Miya Bm Label ), MYSLEE (View Myslee Review and Myslee Label ), MYOCOR (View Myocor Review and Myocor Label ).

6582025-3 | Cerebrovascular Accident, Status Epilepticus
Patient was taking Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, status epilepticus on Feb 10, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Cravit dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), DEPAKENE (View Depakene Review and Depakene Label ), CERCINE (View Cercine Review and Cercine Label ). Patient was hospitalized.

6576371-7 | Beta 2 Microglobulin Increased, Glucose Urine Present, Lymphocyte Stimulation Test Positive, Nephritis, Renal Disorder, Urine Output Decreased
Adverse event was reported on Feb 03, 2010 by a Male patient taking Cravit (View Usage) (Dosage: 200 Mg, 3 In 1 Day) was diagnosed with pyrexia, infection parasitic and. Location: JAPAN , child 9 years of age, Patient had the following side effects: beta 2 microglobulin increased, glucose urine present, lymphocyte stimulation test positive, nephritis, renal disorder, urine output decreased. During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), CALONAL (10 Tablets Of 300 Mg For 3 Days As Necessary) (View Calonal Review and Calonal Label ), SALICYLAMIDE/ACETAMIN/CAFFEINE/PROMETHAZINE (View Salicylamide/acetamin/caffeine/promethazine Review and Salicylamide/acetamin/caffeine/promethazine Label ), NAUZELIN (View Nauzelin Review and Nauzelin Label ), FLOMOX (View Flomox Review and Flomox Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ). Patient was hospitalized.

6570534-2 | Renal Disorder
on Jan 26, 2010 Male patient from JAPAN , child 9 years of age, was diagnosed with pyrexia, infection parasitic and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: renal disorder. Cravit dosage: 200 Mg, 3 In 1 Day. During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), CALONAL (10 Tablets Of 300 Mg For 3 Days As Necessary) (View Calonal Review and Calonal Label ), SALICYLAMIDE/ACETAMIN/CAFFEINE/PROMETHAZINE (View Salicylamide/acetamin/caffeine/promethazine Review and Salicylamide/acetamin/caffeine/promethazine Label ), NAUZELIN (View Nauzelin Review and Nauzelin Label ), FLOMOX (View Flomox Review and Flomox Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ). Patient was hospitalized.

6558508-9 | Cerebral Infarction, Dyspnoea, Oliguria, Pleural Effusion
on Jan 21, 2010 Male patient from JAPAN , 77 years of age, was diagnosed with cystitis and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, dyspnoea, oliguria, pleural effusion. Cravit dosage: . During the same period patient was treated with MEVALOTIN (View Mevalotin Review and Mevalotin Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), TENORMIN (View Tenormin Review and Tenormin Label ), DIOVAN (View Diovan Review and Diovan Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), GASTER D (View Gaster D Review and Gaster D Label ), AMARYL (View Amaryl Review and Amaryl Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ).

6557422-2 | Altered State Of Consciousness
Patient was taking Cravit (View Usage). Patient had the following side effects: altered state of consciousness on Jan 18, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Cravit dosage: . Patient was hospitalized.

6554715-X | Glucose Urine Present, Nephritis
Adverse event was reported on Jan 19, 2010 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with pyrexia and. Location: JAPAN , child 9 years of age, After Cravit was administered, patient had the following side effects: glucose urine present, nephritis. During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), CALONAL (View Calonal Review and Calonal Label ), BIOFERMIN R (View Biofermin R Review and Biofermin R Label ), FLOMOX (View Flomox Review and Flomox Label ). Patient was hospitalized.

6554308-4 | Erythema, Eye Pruritus, Urticaria
on Jan 18, 2010 Female patient from JAPAN , 15 years of age, was diagnosed with thermal burn, purulence and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, eye pruritus, urticaria. Cravit dosage: . During the same period patient was treated with THERADIA C PASTA (View Theradia-c-pasta Review and Theradia-c-pasta Label ), ACTOSIN (View Actosin Review and Actosin Label ).

6549006-7 | Anaphylactic Shock, Coordination Abnormal, Cyanosis, Dysphonia, Hypoaesthesia, Pharyngeal Erythema
on Jan 15, 2010 Female patient from JAPAN , 29 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Cravit (View Usage). Patient had the following side effects: anaphylactic shock, coordination abnormal, cyanosis, dysphonia, hypoaesthesia, pharyngeal erythema. Cravit dosage: . During the same period patient was treated with CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), IPD (View Ipd Review and Ipd Label ).

6547525-0 | Intraocular Pressure Increased, Uveitis
Patient was taking Cravit (View Usage). After Cravit was administered, patient had the following side effects: intraocular pressure increased, uveitis on Jan 13, 2010 from JAPAN Additional patient health information: Female patient , 64 years of age, was diagnosed with cystitis and. Cravit dosage: .

6547517-1 | Altered State Of Consciousness
Adverse event was reported on Jan 12, 2010 by a Female patient taking Cravit (View Usage) (Dosage: ) . Location: JAPAN , 84 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness. Patient was hospitalized.

6539313-6 |
on Jan 08, 2010 Female patient from JAPAN , 80 years of age, was diagnosed with pharyngitis, laryngitis, hypertension and was treated with Cravit (View Usage). . Cravit dosage: . During the same period patient was treated with LYSOZYME HYDROCHLORIDE (View Lysozyme Hydrochloride Review and Lysozyme Hydrochloride Label ), AZUNOL (View Azunol Review and Azunol Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), ATELEC (Initiated Befor Starting Levofloxacin) (View Atelec Review and Atelec Label ), DIOVANE (Initiated Before Starting Levofloxacin) (View Diovane Review and Diovane Label ).

6539300-8 | Anaphylactoid Reaction, Cyanosis, Dysphonia, Pharyngeal Erythema
on Jan 06, 2010 Female patient from JAPAN , 29 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: anaphylactoid reaction, cyanosis, dysphonia, pharyngeal erythema. Cravit dosage: . During the same period patient was treated with CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), IPD (View Ipd Review and Ipd Label ).

6535399-3 | Gaze Palsy, Loss Of Consciousness, Toxic Encephalopathy, Vomiting
Patient was taking Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: gaze palsy, loss of consciousness, toxic encephalopathy, vomiting on Jan 06, 2010 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with cystitis and. Cravit dosage: . Patient was hospitalized.

6524631-8 | Duodenal Ulcer
Adverse event was reported on Dec 24, 2009 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with campylobacter gastroenteritis, enteritis infectious, reflux oesophagitis and. Location: JAPAN , 66 years of age, Patient had the following side effects: duodenal ulcer. During the same period patient was treated with LEBENIN (View Lebenin Review and Lebenin Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6523658-X | Dyspnoea, Erythema, Eyelid Oedema, Laryngeal Oedema, Oropharyngeal Discomfort
on Dec 22, 2009 Female patient from JAPAN , 33 years of age, was diagnosed with cystitis, oropharyngeal discomfort, eyelid oedema and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: dyspnoea, erythema, eyelid oedema, laryngeal oedema, oropharyngeal discomfort. Cravit dosage: . During the same period patient was treated with SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ).

6518484-1 | Gaze Palsy, Loss Of Consciousness, Toxic Encephalopathy, Vomiting
on Dec 15, 2009 Female patient from JAPAN , 31 years of age, was diagnosed with cystitis and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: gaze palsy, loss of consciousness, toxic encephalopathy, vomiting. Cravit dosage: . Patient was hospitalized.

6500066-9 | Liver Disorder, Renal Disorder
Patient was taking Cravit (View Usage). Patient had the following side effects: liver disorder, renal disorder on Dec 07, 2009 from JAPAN Additional patient health information: Male patient , 40 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Cravit dosage: . During the same period patient was treated with ISEPAMICIN SULFATE (View Isepamicin Sulfate Review and Isepamicin Sulfate Label ). Patient was hospitalized.

6498784-4 | Cardiac Failure Congestive, Interstitial Lung Disease, Respiratory Failure
Adverse event was reported on Nov 25, 2009 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with prostatitis, pulmonary mycosis, cough, herpes zoster and. Location: JAPAN , weighting 123.5 lb, After Cravit was administered, patient had the following side effects: cardiac failure congestive, interstitial lung disease, respiratory failure. During the same period patient was treated with ITRIZOLE (View Itrizole Review and Itrizole Label ), EPHEDRA TEAS (View Ephedra Teas Review and Ephedra Teas Label ), PELEX (View Pelex Review and Pelex Label ), SHOUSEIRYUUTOU (View Shouseiryuutou Review and Shouseiryuutou Label ), FLOMOX (View Flomox Review and Flomox Label ), SHAKUYAKUKANZOUTOU (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

6486493-7 | Hepatic Function Abnormal, Pneumonia
on Dec 02, 2009 Female patient from JAPAN , 61 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, pneumonia (What is pneumonia?). Cravit dosage: . During the same period patient was treated with PELEX (View Pelex Review and Pelex Label ), LYSOZYME HYDROCHLORIDE (View Lysozyme Hydrochloride Review and Lysozyme Hydrochloride Label ), MEDICON (View Medicon Review and Medicon Label ). Patient was hospitalized.

6477828-X | Abdominal Discomfort, Dyspnoea, Peripheral Coldness, Somnolence
on Nov 26, 2009 Female patient from JAPAN , weighting 99.21 lb, was diagnosed with pharyngitis, acute sinusitis, gastritis prophylaxis and was treated with Cravit (View Usage). Patient had the following side effects: abdominal discomfort, dyspnoea, peripheral coldness, somnolence. Cravit dosage: . During the same period patient was treated with EBASTINE (View Ebastine Review and Ebastine Label ), ANTOBRON (View Antobron Review and Antobron Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), MEFENAMIC ACID (View Mefenamic Acid Review and Mefenamic Acid Label ). Patient was hospitalized.

6466046-7 | Hepatic Function Abnormal, Pneumonia
Patient was taking Cravit (View Usage). After Cravit was administered, patient had the following side effects: hepatic function abnormal, pneumonia (What is pneumonia?) on Nov 24, 2009 from JAPAN Additional patient health information: Female patient , 61 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Cravit dosage: . During the same period patient was treated with PELEX (View Pelex Review and Pelex Label ), LYSOZYME HYDROCHLORIDE (View Lysozyme Hydrochloride Review and Lysozyme Hydrochloride Label ), MEDICON (View Medicon Review and Medicon Label ). Patient was hospitalized.

6463822-1 | Cerebral Haemorrhage, Colitis Ulcerative, Hepatic Atrophy, Hepatitis Fulminant
Adverse event was reported on Nov 24, 2009 by a Female patient taking Cravit (View Usage) (Dosage: ) . Location: JAPAN , 36 years of age, Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, colitis ulcerative, hepatic atrophy, hepatitis fulminant. Patient was hospitalized.

6463819-1 | Urinary Retention, Urticaria
on Nov 20, 2009 Male patient from JAPAN , 57 years of age, was diagnosed with infection prophylaxis and was treated with Cravit (View Usage). Patient had the following side effects: urinary retention, urticaria. Cravit dosage: . During the same period patient was treated with TAMIFLU (View Tamiflu Review and Tamiflu Label ).

6460499-6 | Gaze Palsy, Loss Of Consciousness
on Nov 18, 2009 Female patient from JAPAN , 31 years of age, was diagnosed with cystitis and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: gaze palsy, loss of consciousness. Cravit dosage: .

6460498-4 | Duodenal Ulcer
Patient was taking Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: duodenal ulcer on Nov 17, 2009 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with campylobacter gastroenteritis, enteritis infectious, reflux oesophagitis and. Cravit dosage: . During the same period patient was treated with LEBENIN (View Lebenin Review and Lebenin Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6456055-6 | Emphysema, Hyponatraemia, Pyrexia
Adverse event was reported on Nov 13, 2009 by a Male patient taking Cravit (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: JAPAN , 80 years of age, Patient had the following side effects: emphysema, hyponatraemia, pyrexia. During the same period patient was treated with SOLIGEN (View Soligen Review and Soligen Label ). Patient was hospitalized.

6456049-0 | Shock, Urticaria
on Nov 13, 2009 Male patient from JAPAN , 38 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Cravit (View Usage). After Cravit was administered, patient had the following side effects: shock, urticaria. Cravit dosage: . During the same period patient was treated with AMINOPHYLLINE (View Aminophylline Review and Aminophylline Label ), SAXIZON (View Saxizon Review and Saxizon Label ).

6450029-7 | Cerebrovascular Accident, Status Epilepticus
on Nov 12, 2009 Male patient from JAPAN , 85 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Cravit (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, status epilepticus. Cravit dosage: . During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), DEPAKENE (View Depakene Review and Depakene Label ), CERCINE (View Cercine Review and Cercine Label ). Patient was hospitalized.

6450026-1 | Abdominal Pain Upper, Agitation, Confusional State, Fall, Headache, Malaise, Pyelonephritis
Patient was taking Cravit (View Usage). Patient had the following side effects: abdominal pain upper, agitation, confusional state, fall (What is fall?), headache (What is headache?), malaise, pyelonephritis on Nov 13, 2009 from JAPAN Additional patient health information: Female patient , 44 years of age, . Cravit dosage: . During the same period patient was treated with MEDICON (View Medicon Review and Medicon Label ), CALONAL (View Calonal Review and Calonal Label ).